COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
Main Authors: | Newton, PN, Bond, KC, 53 signatories from 20 countries |
---|---|
Other Authors: | Naughton, B |
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
Global access to quality-assured medical products: the Oxford Statement and call to action
by: Newton, P, et al.
Published: (2019) -
Translation as Research: A Manifesto
by: Diverse Signatories
Published: (2015-11-01) -
Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance
by: Tabernero, P, et al.
Published: (2023) -
FINANCING THE PRODUCTION AND SUPPLY OF COVID-19 VACCINES
by: T. Anev
Published: (2022-12-01) -
Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains
by: Bharucha, T, et al.
Published: (2024)